Biopharmaceutical Excipients Market worth $4.70 billion by 2030, growing at a CAGR of 10.75% - Exclusive Report by 360iResearch

The "Biopharmaceutical Excipients Market by Product (Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers), Function (Binders, Coatings, Disintegrants), Application - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Biopharmaceutical Excipients Market to grow from USD 2.29 billion in 2023 to USD 4.70 billion by 2030, at a CAGR of 10.75%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/biopharmaceutical-excipients?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Biopharmaceutical excipients are substances other than therapeutic molecules that are included in a biopharmaceutical formulation to aid in the production, stability, usability, and delivery of the drug. Biopharmaceutical excipients play a pivotal role in drug formulation. Their applications span diverse categories, such as binders, fillers, diluents, disintegrants, and stabilizers. Rising demand for advanced and functional biopharmaceutical drug formulations and increasing need for large-molecule development are driving the adoption of biopharmaceutical excipients. In addition, rising investment in drug development is boosting the utilization of biopharmaceutical excipients. However, the compatibility issues of biopharmaceutical formulations with active pharmaceutical ingredients pose considerable challenges. Furthermore, the continuous development of biologics and biosimilars leads to an increased need for compatible excipients. Technological advancements in extended-release formulations and the exploration of alternative routes of administration provide significant potential for market expansion.

In the Americas, the United States stands as a dominant player within the biopharmaceutical excipients market due to a robust pharmaceutical industry, significant investment in R&D, and a steady number of FDA approvals. Canada contributes to regional demand, and both countries exhibit a high interest in novel, multifunctional excipients that enhance drug delivery and stability. European Union (EU) countries possess a well-established pharmaceutical sector with stringent regulatory standards. Consumer need is driven by the production of biosimilars and biologics that demand high-quality ingredients. Ongoing investments by the European Union in research and innovation programs indicate a continued commitment to excipient development, including potential patent applications that aim at improving the performance and safety of biopharmaceuticals. In the APAC region, the focus is on the innovation and development of new excipients and a strong government push for upgrading the pharmaceutical industry. In India, a hub for generic drug production, the excipient demand aligns with cost efficiency and compliance with international standards. Across the Asia Pacific, diverse customer needs steer the demand for specific excipients, which are expected to fuel market growth.

Market Segmentation & Coverage:

This research report categorizes the Biopharmaceutical Excipients Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers, and Specialty Excipients. The Carbohydrates is further studied across Dextrose, Starch, and Sucrose. The Polyols is further studied across Mannitol and Sorbitol. The Solubilizers & Surfactants/Emulsifiers is further studied across Esters and Triglycerides. The Solubilizers & Surfactants/Emulsifiers commanded largest market share of 40.13% in 2023, followed by Specialty Excipients.

Based on Function, market is studied across Binders, Coatings, Disintegrants, Lubricants & glidants, Pharmaceutical Fillers, and Preservatives. The Preservatives commanded largest market share of 21.73% in 2023, followed by Lubricants & glidants.

Based on Application, market is studied across Advanced Delivery System, Oral, Parenteral, and Topical. The Parenteral commanded largest market share of 55.25% in 2023, followed by Advanced Delivery System.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 44.65% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/biopharmaceutical-excipients?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Biopharmaceutical Excipients Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Biopharmaceutical Excipients Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Biopharmaceutical Excipients Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Actylis, Ashland Global Holdings Inc., BASF SE, Clariant International Ltd., Colorcon, Inc., Croda International PLC, DFE Pharma GmbH & Co KG, Eastman Chemical Company, Evonik Industries AG, Fuji Chemical Industries Co., Ltd., IMCD N.V., Innophos Holdings, Inc., J. Rettenmaier & Söhne GmbH + Co KG, Meggle Group GmbH, Merck KGaA, Roquette Frères S.A., Sigachi Industries Limited, Spectrum Laboratory Products, Inc., SPI Pharma, Inc., The Dow Chemical Company, The Lubrizol Corporation, VWR International, LLC by Avantor, and Wacker Chemie AG.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Biopharmaceutical Excipients Market, by Product
7. Biopharmaceutical Excipients Market, by Function
8. Biopharmaceutical Excipients Market, by Application
9. Americas Biopharmaceutical Excipients Market
10. Asia-Pacific Biopharmaceutical Excipients Market
11. Europe, Middle East & Africa Biopharmaceutical Excipients Market
12. Competitive Landscape
13. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Biopharmaceutical Excipients Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Biopharmaceutical Excipients Market?
3. What is the competitive strategic window for opportunities in the Biopharmaceutical Excipients Market?
4. What are the technology trends and regulatory frameworks in the Biopharmaceutical Excipients Market?
5. What is the market share of the leading vendors in the Biopharmaceutical Excipients Market?
6. What modes and strategic moves are considered suitable for entering the Biopharmaceutical Excipients Market?

Read More @ https://www.360iresearch.com/library/intelligence/biopharmaceutical-excipients?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.